Lux Capital is a venture capital firm founded in 2000, specializing in early-stage investments in emerging technologies. The firm focuses on sectors such as artificial intelligence, biotechnology, aerospace, and energy, aiming to support companies that are pioneering advancements in these fields. Lux Capital is known for its contrarian approach, often investing in unconventional ideas and technologies that have the potential to reshape industries.

The firm's portfolio includes notable companies like Anduril, Applied Intuition, and Eikon Therapeutics. Lux Capital has raised several funds over the years, including a $675 million early-stage fund and an $800 million opportunity fund in 2021, totaling $1.475 billion. In April 2023, the firm raised $1.15 billion for its largest fund to date, Lux Ventures VIII, focusing on biotech, AI, and aerospace startups.

The firm's offices are located in New York City and Menlo Park, California.